In the eye of the storm: the right ventricle in COVID‐19

Pulmonary Circulation - Tập 10 Số 3 - Trang 1-7 - 2020
John F. Park1, Somanshu Banerjee1, Soban Umar1
1Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Tóm tắt

The corona virus disease of 2019 pandemic caused by the SARS‐CoV‐2 virus continues to inflict significant morbidity and mortality around the globe. A variety of cardiovascular presentations of SARS‐CoV‐2 infection have been described so far. However, the impact of SARS‐CoV‐2 on the right ventricle is largely unknown. Due to its pathophysiologic relevance, the right ventricle finds itself in the eye of the storm of corona virus disease of 2019, placing it at higher risk of failure. Increased afterload from acute respiratory distress syndrome and pulmonary embolism, negative inotropic effects of cytokines, and direct angiotensin converting enzyme 2‐mediated cardiac injury from SARS‐CoV‐2 are potential mechanisms of right ventricle dysfunction in corona virus disease of 2019. Early detection and treatment of right ventricle dysfunction may lead to decreased mortality and improved patient outcomes in corona virus disease of 2019.

Từ khóa


Tài liệu tham khảo

Guo T, Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID‐19), JAMA Cardiol

Fried JA, The variety of cardiovascular presentations of COVID‐19, Circulation

10.1161/CIRCULATIONAHA.120.046941

Deng Q, Suspected myocardial injury in patients with COVID‐19: evidence from front‐line clinical observation in Wuhan, China, Int J Cardiol

10.1016/j.jcmg.2020.04.014

Shi S, Association of cardiac injury with mortality in hospitalized patients with COVID‐19 in Wuhan, China, JAMA Cardiol

10.1016/j.chest.2017.02.019

10.1007/s00134-013-2941-9

10.1007/s00134-015-4141-2

Fox SE Akmatbekov A Harbert JL et al. Pulmonary and cardiac pathology in Covid‐19: the first autopsy series from New Orleans | medRxiv www.medrxiv.org/content/10.1101/2020.04.06.20050575v1(accessed 21 April 2020).

Varga Z, Endothelial cell infection and endotheliitis in COVID‐19, Lancet

Klok FA, Incidence of thrombotic complications in critically ill ICU patients with COVID‐19, Thromb Res

Ullah W, COVID‐19 complicated by acute pulmonary embolism and right‐sided heart failure, JACC Case Rep

10.2174/157340308783565384

Inciardi RM, Cardiac involvement in a patient with coronavirus disease 2019 (COVID‐19), JAMA Cardiol

10.1111/jth.14768

Wang D, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China, JAMA

Wichmann D, Autopsy findings and venous thromboembolism in patients with COVID‐19, Ann Intern Med

10.1016/j.jcv.2020.104362

10.1177/1076029619887437

10.1159/000453002

Magro C, Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID‐19 infection: a report of five cases, Transl Res

10.1161/CIRCULATIONAHA.120.047349

Sala S, Acute myocarditis presenting as a reverse Tako‐Tsubo syndrome in a patient with SARS‐CoV‐2 respiratory infection, Eur Heart J

10.1093/cvr/cvaa078

10.1161/CIRCRESAHA.120.317015

Becker RC, 2020, COVID‐19 update: Covid‐19‐associated coagulopathy, J Thromb Thrombolysis, 15, 1

10.1056/NEJMra1808137

10.1001/jamacardio.2016.0433

10.1093/eurheartj/ehm035

Madjid M, 2007, Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries, Tex Heart Inst J, 34, 11

10.1186/s13054-014-0469-1

10.1016/j.jacc.2005.01.054

Dominguez‐Erquicia P, Multivessel coronary thrombosis in a patient with COVID‐19 pneumonia, Eur Heart J

Ruan Q, Clinical predictors of mortality due to COVID‐19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med

Moore BJB, Cytokine release syndrome in severe COVID‐19, Science

Dewachter L, Inflammation in right ventricular failure: does it matter?, Front Physiol

Vaduganathan M, Renin‐angiotensin‐aldosterone system inhibitors in patients with Covid‐19, N Engl J Med

Li H, SARS‐CoV‐2 and viral sepsis: observations and hypotheses, Lancet

10.1016/S0140-6736(20)30566-3

10.1038/s41569-020-0360-5

Sydykov A, Inflammatory mediators drive adverse right ventricular remodeling and dysfunction and serve as potential biomarkers, Front Physiol

Zamanian RT, Outpatient inhaled nitric oxide in a patient with vasoreactive IPAH and COVID‐19 infection, Am J Respir Crit Care Med

10.1002/path.1570

10.1038/nature03712

10.1161/01.HYP.0000205833.89478.5b

10.1164/rccm.201712-2570OC

10.1016/j.coph.2017.12.002

10.1177/1470320315576256

10.1152/ajplung.00009.2008

Sandoval J, Angiotensin converting enzyme 2 and angiotensin (1‐7) axis in pulmonary arterial hypertension, Eur Respir J

10.1097/CCM.0b013e3181c03009

10.1161/HYPERTENSIONAHA.108.125468

Guignabert C, ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad, Eur Respir J

10.1161/hc3401.093149

10.1152/ajpheart.00518.2005

10.1371/journal.pone.0020828

10.1161/CIRCULATIONAHA.112.094722

10.1164/rccm.201202-0335OC

10.1186/1465-9921-10-6

Koudstaal T, Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an immunological perspective, J Clin Med

10.1161/CIRCRESAHA.108.182014

10.1016/j.healun.2017.08.011

10.1038/s41598-016-0028-x

10.1016/j.antiviral.2017.03.022

Thông tin
Thông tin xuất bản

Pulmonary Circulation

Tập 10 Số 3

1-7

Thông tin tác giả